ROYALTY PHARMA PLC- CL A (RPRX) Stock Cash Flow
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 13.47M | 57.88M | 38.43M | -113.00M | -213.30M | |||
| Interest Paid | -219.42M | -159.57M | -169.17M | -170.10M | -130.40M | |||
| OPERATING CASH FLOW | 2.70B | 2.77B | 2.99B | 2.14B | 2.02B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.42B | -2.51B | -2.12B | -1.74B | -2.19B | |||
| Other Investing Activity | 333.13M | -172.41M | 42.73M | 712.20M | 321.20M | |||
| INVESTING CASH FLOW | -2.09B | -2.68B | -2.07B | -1.03B | -1.87B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 1.47B | -1.00B | 0.00 | 1.27B | |||
| Stock Issued/Repurchased | N/A | -229.65M | -304.76M | 0.00 | 0.00 | |||
| Dividend Paid | -378.02M | -376.46M | -358.33M | -333.30M | -285.20M | |||
| Other Financing Activity | -522.94M | -503.97M | -485.67M | -611.50M | -602.20M | |||
| FINANCING CASH FLOW | -368.16M | 361.14M | -2.15B | -944.90M | 385.10M | |||
| CHANGE IN CASH | 244.72M | 452.02M | -1.23B | 169.70M | 532.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 2.70B | 2.77B | 2.99B | 2.14B | 2.02B | |||
| Capital Expenditure | -2.42B | -2.51B | -2.12B | -1.74B | -2.19B | |||
| FREE CASH FLOW | 279.75M | 263.29M | 872.28M | 402.40M | -174.00M | |||
All data in USD